Literature DB >> 24980513

Biallelic mutations at PPARG cause a congenital, generalized lipodystrophy similar to the Berardinelli-Seip syndrome.

D A Dyment1, W T Gibson2, L Huang3, H Bassyouni4, R A Hegele5, A M Innes6.   

Abstract

We present an individual with a generalized and infantile onset lipodystrophy who later developed hypertriglyceridemia, pancreatitis, refractory diabetes, irregular menses and renal failure. She showed the hallmark features of a congenital, generalized lipodystrophy (CGL). Sequencing PPARG identified two pathogenic mutations; c.413_416delAATG; p.Glu138ValfsX168 and c.490C>T; p.R164W. The phenotype and presence of two mutations suggests that biallelic mutations at PPARG cause a CGL similar to that observed with biallelic AGPAT2 or BSCL2 mutations.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Congenital generalized lipodystrophy; Diabetes; Hypertriglyceridemia; PPARG

Mesh:

Substances:

Year:  2014        PMID: 24980513     DOI: 10.1016/j.ejmg.2014.06.006

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  14 in total

Review 1.  Phenotypic and Genetic Characteristics of Lipodystrophy: Pathophysiology, Metabolic Abnormalities, and Comorbidities.

Authors:  Baris Akinci; Rasimcan Meral; Elif Arioglu Oral
Journal:  Curr Diab Rep       Date:  2018-11-08       Impact factor: 4.810

2.  Clinical Utility Gene Card for: Familial partial lipodystrophy.

Authors:  Isabelle Jéru; Camille Vatier; David Araujo-Vilar; Corinne Vigouroux; Olivier Lascols
Journal:  Eur J Hum Genet       Date:  2016-08-03       Impact factor: 4.246

Review 3.  Lipodystrophy for the Diabetologist-What to Look For.

Authors:  Nivedita Patni; Abhimanyu Garg
Journal:  Curr Diab Rep       Date:  2022-07-11       Impact factor: 5.430

Review 4.  Congenital generalized lipodystrophies--new insights into metabolic dysfunction.

Authors:  Nivedita Patni; Abhimanyu Garg
Journal:  Nat Rev Endocrinol       Date:  2015-08-04       Impact factor: 43.330

Review 5.  What lipodystrophies teach us about the metabolic syndrome.

Authors:  Jake P Mann; David B Savage
Journal:  J Clin Invest       Date:  2019-08-05       Impact factor: 14.808

Review 6.  Metabolic syndrome: genetic insights into disease pathogenesis.

Authors:  Maen D Abou Ziki; Arya Mani
Journal:  Curr Opin Lipidol       Date:  2016-04       Impact factor: 4.776

7.  Berardinelli-Seip syndrome and achalasia: a shared pathomechanism?

Authors:  Rachel J van der Pol; Marc A Benninga; Jocelyne Magré; Lionel Van Maldergem; Joost Rotteveel; Marjo S van der Knaap; Tim G de Meij
Journal:  Eur J Pediatr       Date:  2015-05-22       Impact factor: 3.183

Review 8.  Is the Mouse a Good Model of Human PPARγ-Related Metabolic Diseases?

Authors:  Attila Pap; Ixchelt Cuaranta-Monroy; Matthew Peloquin; Laszlo Nagy
Journal:  Int J Mol Sci       Date:  2016-07-30       Impact factor: 5.923

Review 9.  The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline.

Authors:  Rebecca J Brown; David Araujo-Vilar; Pik To Cheung; David Dunger; Abhimanyu Garg; Michelle Jack; Lucy Mungai; Elif A Oral; Nivedita Patni; Kristina I Rother; Julia von Schnurbein; Ekaterina Sorkina; Takara Stanley; Corinne Vigouroux; Martin Wabitsch; Rachel Williams; Tohru Yorifuji
Journal:  J Clin Endocrinol Metab       Date:  2016-10-06       Impact factor: 5.958

Review 10.  Maintenance of Kidney Metabolic Homeostasis by PPAR Gamma.

Authors:  Patricia Corrales; Adriana Izquierdo-Lahuerta; Gema Medina-Gómez
Journal:  Int J Mol Sci       Date:  2018-07-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.